LabConnect and Bostwick Scientific Launch Centralized Anatomic Pathology Testing Service
Clinical and Anatomic Central Laboratory Services Combined
SEATTLE, WA-April 4, 2008-Central laboratory services provider LabConnect, announced today that it has signed Bostwick Scientific, the clinical trials division of Bostwick Laboratories, the world’s largest provider of centralized anatomic pathology testing services for clinical trials, as an exclusive provider.
The combination of Bostwick Scientific and LabConnect provide clinical trial sponsors with one source for key opinion leaders in anatomic pathology and central laboratory experts and combine the country’s fastest growing anatomic pathology lab and central lab. Bostwick Laboratories was formed in 1999 by David G. Bostwick, MD, MBA an internationally renowned expert in urologic pathology. Bostwick Laboratories operates six facilities in the U.S. and Europe and provides histological and cytological diagnosis in human pathology with special expertise in urogenital, gastrointestinal, gynecological, dermatologic and hematologic pathology. Bostwick Scientific has processed more than 35,000 clinical trial cases to date.
“We’re in the early stages of the evolution of anatomic pathology testing in clinical trials,” noted Eric Hayashi, LabConnect president and chief executive officer. “Sponsors are increasingly realizing the benefits of the centralization of their anatomic pathology testing needs just as they have realized similar benefits in centralizing routine and specialized clinical pathology.”
About LabConnect, LLC
LabConnect ( www.labconnectllc.com ), established in 2002, is a leading provider of central laboratory services to the biopharmaceutical industry. LabConnect’s global network of world-class laboratories provide an extensive menu of clinical trial testing services and have supported hundreds of clinical trials ranging from small single-site to large global studies with complex testing and logistical requirements.
About Bostwick Laboratories
Bostwick Laboratories ( www.bostwicklaboratories.com ) is a specialized anatomic pathology laboratory focused on the diagnosis of cancer. Bostwick Laboratories is a leader in urologic anatomic pathology, with expertise and a growing presence in the nephrology, gynecology, gastroenterology, and hematology sectors of the anatomic pathology market. Bostwick Laboratories is headquartered in Glen Allen, VA, and operates six laboratories located in VA, AZ, NY, FL, TN, and London, UK.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.
